Serious Shortage Protocols ( SSP's )

In February 2019, the Human Medicines Regulations 2012 were amended to introduce Serious Shortage Protocols (SSPs).

 Further changes will come into operation on 31 October 2019 in The Pharmaceutical Services (Amendments Relating to Serious Shortage Protocols) Regulations (Northern Ireland) 2019. 

An SSP enables community pharmacists to supply a specified medicine in accordance with a protocol rather than a prescription and without the need to seek authorisation from the prescriber.  An SSP would only be used in the case of a serious shortage if it is considered that it would help manage the supply situation.

Further information on SSPs will be made available on this page.   

 Last updated: 11th August 2020

 

 

Serious Shortage Protocol - Fluoxetine 40mg Caps - UPDATE - 11th August 2020

SSP - Fluoxetine 40mg Caps - Ministerial Sign Off - UPDATE - 11th August 2020

Serious Shortage Protocol - Fluoxetine 40mg Caps - UPDATE - 20th July 2020

SSP - Fluoxetine 40mg Caps - Ministerial Sign Off - UPDATE

MPS 2664 - Serious Shortage Protocol - Submission Information 27.05.20

Serious Shortage Protocol - Fluoxetine 40mg Caps - 20th May 2020

SSP - Fluoxetine 40mg Caps - Ministerial Sign Off

Fluoxetine 10mg tabs - important information - 12th March 2020

New Measures To Help Manage Medicines Shortages

Updated List of Medicines Which Cannot be Paralled Exported

Serious Shortage Protocols Letter

SSP Guidance - Northern Ireland

Serious Shortage Protocol - FAQ's

Patient Information Leaflet

Serious Shortage Protocol Remuneration 2019/20